+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point of Care Molecular Diagnostics Market by Product Type, Technology, Application, End User, Format - Global Forecast to 2030- Product Image
Point of Care Molecular Diagnostics Market by Product Type, Technology, Application, End User, Format - Global Forecast to 2030- Product Image
Sale

Point of Care Molecular Diagnostics Market by Product Type, Technology, Application, End User, Format - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5639415
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Point of Care Molecular Diagnostics Market is transforming clinical practice by decentralizing laboratory capabilities, delivering rapid results at the site of patient care. This shift enhances operational efficiency and informs timely treatment decisions for healthcare organizations and their partners.

Market Snapshot: Point of Care Molecular Diagnostics Market

The Point of Care Molecular Diagnostics Market grew from USD 2.95 billion in 2024 to USD 3.25 billion in 2025. It is expected to continue growing at a CAGR of 9.73%, reaching USD 5.16 billion by 2030. Demand is driven by the decentralization of testing, pressures on traditional laboratory infrastructure, and increasing roles in infectious disease control, genetic screening, and oncology diagnostics. The market is propelled by innovation in assay sensitivity, move toward portable platforms, and integration of real-time software for clinical use.

Scope & Segmentation

This report provides a comprehensive analysis structured by segment, region, and market activity. Key dimensions include:

  • Product Types: Instruments, reagents & kits, and software that underpin diagnostic workflows and enable data analysis at the point of care.
  • Technology Platforms: Hybridization assays (FISH, microarray), isothermal amplification (LAMP, NASBA, RPA), various PCR methods (dPCR, qPCR, RT-PCR), and sequencing (next generation, Sanger) technologies available for near-patient molecular testing.
  • Applications: Diverse use cases in cardiology, genetic testing (including carrier, newborn, and prenatal screening), infectious disease (gastrointestinal, respiratory, sexually transmitted, and tropical), and oncology (liquid biopsy, mutation profiling, oncogene panels).
  • End Users: Clinics, diagnostic laboratories, home care, hospitals, reference laboratories.
  • Formats: Benchtop, portable, and wearable device models that accommodate fixed-site, decentralized, and continuous patient monitoring demands.
  • Geographies: Extensive coverage of Americas (including United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (spanning UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and more), and Asia-Pacific (China, India, Japan, Australia, South Korea, ASEAN markets, and others).
  • Leading Companies: Roche Diagnostics International AG, Abbott Laboratories, Cepheid Inc., bioMérieux SA, Qiagen N.V., Becton Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific Inc., Siemens Healthineers AG, Meridian Bioscience, Inc.

Key Takeaways

  • Technological advancement—including isothermal amplification, digital PCR, and microarray refinement—is spurring the adoption of point of care molecular diagnostics across multiple clinical specialties.
  • Miniaturized and software-integrated platforms are driving the evolution from traditional laboratories toward on-site, near-patient, and remote testing, expanding clinical reach and operational flexibility for providers.
  • Diversification of device formats, from portable instruments to emerging wearable molecular systems, is responding to clinical demand for mobility and continuous monitoring capabilities.
  • Strategic partnerships and local alliances are gaining importance as organizations navigate regulatory requirements, reimbursement policies, and global distribution challenges unique to each region.
  • Customizing product offerings for specific end user segments—clinics, hospitals, laboratories, and home care—enables technology suppliers to capture new growth opportunities in an increasingly segmented market.

Tariff Impact: Navigating 2025 US Tariffs

The introduction of new US tariffs in 2025 adds complexity for manufacturers and supply chain partners. Elevated costs for imported instruments, reagents, and kits encourage supply chain reassessment, with firms considering near-shoring and new supplier alliances to mitigate financial risk. Distributors are recalibrating inventory strategies, striving for resilience while maintaining cost-efficiency. These trade measures act as a catalyst for operational shifts and geographic diversification among market participants.

Methodology & Data Sources

This report is built on a rigorous research process that combines secondary data review (regulatory filings, peer-reviewed literature, financial reports) with primary interviews among key opinion leaders from laboratory operations, research, and policy. Quantitative metrics were triangulated, while qualitative evidence included validation of case studies and technology deployments. Peer review steps ensured accuracy and minimized bias throughout all findings.

Why This Report Matters

  • Empowers executives and strategic planners with validated market landscape analysis and actionable segmentation insight.
  • Supports investment decisions by detailing regulatory pathways, operational risks, and core technology trends influencing adoption and competitive strategy.
  • Supplies clear benchmarks for evaluating partnership opportunities, product positioning, and business model resilience within an evolving global diagnostics sector.

Conclusion

The Point of Care Molecular Diagnostics Market is poised for accelerated change, shaped by ongoing regulatory adaptation and fast-evolving technology. Leaders who align with segmentation trends, strengthen operational agility, and foster strategic partnerships will capture growth in this dynamic space.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Point of Care Molecular Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.3. Reagents & Kits
8.4. Software
9. Point of Care Molecular Diagnostics Market, by Technology
9.1. Introduction
9.2. Hybridization Assays
9.2.1. FISH
9.2.2. Microarray
9.3. Isothermal Amplification
9.3.1. LAMP
9.3.2. NASBA
9.3.3. RPA
9.4. PCR
9.4.1. dPCR
9.4.2. qPCR
9.4.3. RT-PCR
9.5. Sequencing
9.5.1. Next Generation Sequencing
9.5.2. Sanger Sequencing
10. Point of Care Molecular Diagnostics Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Genetic Testing
10.3.1. Carrier Screening
10.3.2. Newborn Screening
10.3.3. Prenatal Testing
10.4. Infectious Disease
10.4.1. Gastrointestinal Infections
10.4.2. Respiratory Infections
10.4.3. Sexually Transmitted Infections
10.4.4. Tropical Diseases
10.5. Oncology
10.5.1. Liquid Biopsy
10.5.2. Mutation Profiling
10.5.3. Oncogene Panel
11. Point of Care Molecular Diagnostics Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Diagnostic Laboratories
11.4. Home Care Settings
11.5. Hospitals
11.6. Reference Laboratories
12. Point of Care Molecular Diagnostics Market, by Format
12.1. Introduction
12.2. Benchtop
12.3. Portable
12.4. Wearable
13. Americas Point of Care Molecular Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Point of Care Molecular Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Point of Care Molecular Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Roche Diagnostics International AG
16.3.2. Abbott Laboratories
16.3.3. Cepheid Inc.
16.3.4. bioMérieux SA
16.3.5. Qiagen N.V.
16.3.6. Becton Dickinson and Company
16.3.7. Hologic, Inc.
16.3.8. Thermo Fisher Scientific Inc.
16.3.9. Siemens Healthineers AG
16.3.10. Meridian Bioscience, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY LAMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY NASBA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY RPA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY DPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY RT-PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TROPICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY MUTATION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOGENE PANEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY WEARABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 86. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 88. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 89. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 91. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 92. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 93. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. CANADA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 95. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 100. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 101. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 103. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 156. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 159. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 160. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 161. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 162. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 164. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 165. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 166. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 168. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 173. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 174. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 176. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 178. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 192. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 195. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 196. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 197. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 198. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 200. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 201. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 202. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 204. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 209. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 210. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 212. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 214. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 252. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 255. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 256. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 257. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 258. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 260. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 261. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 262. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. DENMARK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 276. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 279. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 280. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 281. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 282. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 284. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 285. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 286. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. QATAR POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 288. FINLAND POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. FINLAND POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. FINLAND POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION ASSAYS, 2018-2030 (USD MILLION)
TABLE 291. FINLAND POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 292. FINLAND POINT OF CARE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 293. FINLAND POINT OF CARE MOLECULAR DIAGNOSTIC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Point of Care Molecular Diagnostics market report include:
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • Cepheid Inc.
  • bioMérieux SA
  • Qiagen N.V.
  • Becton Dickinson and Company
  • Hologic, Inc.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Meridian Bioscience, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.16 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2025-2033 - Product Image

Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2025-2033

  • Report
  • 139 Pages
  • Global
From
Point-of-Care Molecular Diagnostics Market Report 2025 - Product Image

Point-of-Care Molecular Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Point of Care (POC) Molecular Diagnostics - Global Strategic Business Report - Product Image

Point of Care (POC) Molecular Diagnostics - Global Strategic Business Report

  • Report
  • 597 Pages
  • Global
From
Point of Care Molecular Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Point of Care Molecular Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 153 Pages
  • Global
From
POC Molecular Diagnostics Market 2024-2028 - Product Image

POC Molecular Diagnostics Market 2024-2028

  • Report
  • 172 Pages
  • Global
From

About the POC Molecular Diagnostics Market

Point-of-Care (POC) Molecular Diagnostics is a rapidly growing field of medical diagnostics that enables the detection of genetic material from a patient sample at the point of care. This technology is used to detect and diagnose a wide range of diseases, including infectious diseases, cancer, and genetic disorders. POC Molecular Diagnostics offers a number of advantages over traditional laboratory-based testing, including faster turnaround times, improved accuracy, and cost savings. POC Molecular Diagnostics is used in a variety of settings, including hospitals, clinics, and laboratories. It is also increasingly being used in home settings, allowing patients to self-test for a variety of conditions. This technology is also being used in the field of public health, allowing for rapid detection and response to outbreaks of infectious diseases. Some companies in the POC Molecular Diagnostics market include Cepheid, Hologic, Abbott, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.